Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) has announced the resumption of patient enrollment in a Phase 1/2 clinical trial evaluating seclidemstat combined with azacitidine for myelodysplastic ...
Michal Mego, winner of 2024, ESET Science Award public prize, founded top research lab when he returned to Slovakia.
Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective ...
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...
Researchers have identified two microRNA that may predict which individuals with cancer are at elevated risk for ...
The Mayo Clinic provides a perspective on 7 ways that individuals can reduce their risk: Eat healthier foods (thereby also ...
A case study of compassion fatigue, based on the experience of one oncologist, highlighted that the condition parallels ...
6d
Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...
Rice University chemist and director of the university’s Synthesis X Center Han Xiao and cancer biologist Dihua Yu of The ...
6d
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...
BOSTON - Bicara Therapeutics Inc. (NASDAQ:BCAX), a clinical-stage biotech company with a market capitalization of $631 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback